Study of psoriasis and related co-morbid conditions
DOI:
https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20220366Keywords:
Psoriasis, Co-morbidities, Metabolic syndromeAbstract
Background: Psoriasis is a chronic, inflammatory papulosquamous disorder of the skin in which both genetic and environmental factors have a crucial role. Comorbidities tend to arise in complex disorders; they are usually multifactorial and most frequently demonstrate an inflammatory pathology. Aim and objectives of the study include: to determine the occurrence of comorbidities; to determine if the presence of these comorbidities is related to the severity of psoriasis; and to determine if the presence of comorbidities is related to the duration of psoriasis.
Methods: 100 patients diagnosed with psoriasis, attending DVL OPD of a tertiary care teaching hospital were enrolled based on inclusion and exclusion criteria. General, systemic examination and relevant investigations are done to determine co-morbidities in these patients.
Results: Among 100 patients, 70 (70%) patients were having comorbidities. Most of the patients had one comorbidity (38%) followed by two comorbidities (16%) and more than two comorbidities (15%). Dyslipidemia (56%) was the commonest comorbidity followed by diabetes mellitus (23%), obesity (20%), hypertension (18%) and metabolic syndrome (15%). 76% of patients with severe disease and 68% of patients were having mild to moderate psoriasis had co-morbidities. Among 80 patients with less than 5 years of disease duration, only 54 (67.5%) patients were having comorbidities. While 20 patients with more than 5 years of duration of disease, 16 (80%) were having comorbidities.
Conclusions: Wide range of co-morbid conditions are associated with psoriasis. The need for comprehensive screening and treatment must be recognized and addressed.
Metrics
References
Nadi L. Epidemiology of Psoriasis. Curr Drug Targets Inflamm Allergy. 2004;3:121.
Ambady BM, Gopinath T, Nair BKH. Psoriasis. Indian J Dermatol Venereol Leprol. 1961;23:27-34.
Augustin M, Glaeske G, Radtke MA, Christophers E, Reich K, Schäfer I. Epidemiology and comorbidity of psoriasis in children. Br J Dermatol. 2010;162(3):633-6.
Christophers E. Comorbidities in psoriasis. Clin Dermatol. 2007;25(6):529-34.
Habif TP. Psoriasis and other papulosquamous diseases - Textbook of clinical dermatology. 5th edition. Elsevier. 2015..
Gulliver WP. Importance of screening for comorbidities in psoriasis patients. Expert Rev Dermatol. 2008;3(2),133-5.
Gerdes S, Mrowietz U. Impact of comorbidities on the management of psoriasis. Curr Probl Dermatol. 2009;38:21-36.
Gerdes S, Zahl VA, Knopf H, Weichenthal M, Mroweitz U. Comedication Related to Comorbidities: A Study in 1,203 Hospitalized Patients With Severe Psoriasis. Br J Dermatol. 2008;159(5):1116-23.
Kaye JA, Li L, Jick SS. Incidence of Risk Factors for Myocardial Infarction and Other Vascular Diseases in Patients With Psoriasis. Br J Dermatol. 2008;159(4):895-902.
Cohen AD, Sherf M, Vidavsky L, Vardy DA, Shapiro J, Meyerovitch J. Association between psoriasis and the metabolic syndrome. A cross-sectional study. Dermatology. 2008;216(2):152-5.
Pearce DJ, Morrison AE, Higgins KB, Crane MM, Balkrishnan R, Fleischer AB Jr, Feldman SR. The comorbid state of psoriasis patients in a university dermatology practice. J Dermatolog Treat. 2005;16(5-6):319-23.
Gisondi P, Tessari G, Conti A, Piaserico S, Schianchi S, Peserico A, Giannetti A, Girolomoni G. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol. 2007;157(1):68-73.
Brauchli YB, Jick SS, Meier CR. Psoriasis and the Risk of Diabetes: A Population-based Study. Br J Dermatol. 2008;159(6):1331-7.
Azfar RS, Gelfand JM. Psoriasis and metabolic disease: epidemiology and pathophysiology. Curr Opin Rheumatol. 2008;20(4);416-22.
Lea WA, Cornish HH, Block WD. Studies on Serum Lipids, Proteins, and Lipoproteins in Psoriasis. J Invest Dermatol. 1958;30:181-5.
Shapiro J, Cohen AD, David M, Hodak E, Chodik G, Viner A, Kremer E, Heymann A. The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study. J Am Acad Dermatol. 2007;56(4):629-34.
Armstrong AW, Lin SW, Chambers CJ, Sokolov ME, Chin DL. Psoriasis and hypertension severity: results from a case-control study. PloS One. 2011;6:e18227.
Thomas J, Ashok KN, Manoharan D, Cynthia S, Selva Prabu SK, Ahmed A. Comorbid conditions associated with Psoriasis. J Indian Soc Teledermatol. 2010;4(1).
Neimann AL, Shin DB, Wang X. Prevalence of cardiovascular risk factors in psoriasis patients. J Amer Acad Dermatol. 2006;55:829-35.
Thomas J, Ashok KN, Manoharan D, Cynthia S, Selva Prabu SK, Ahmed A. Comorbid conditions associated with Psoriasis. J Indian Soc Teledermatol. 2010;4:1.
Bonifati C, Carducci M, Fei PC, Trento E, Sacerdoti G, Fazio M. Correlated increases of tumour necrosis factor-????, interleukin-6 and granulocyte monocyte-colony stimulating factor levels in suction blister fluids and sera of psoriatic patients’ relationships with disease severity. Clin Exp Dermatol. 1994;19:383-7.
Downloads
Published
How to Cite
Issue
Section
